Search

Author/Creator Ogura, Eriko

1. 1292. Safety Profile of the Novel Siderophore Cephalosporin Cefiderocol in Randomized Phase 2 and Phase 3 Clinical Studies of Serious Gram-Negative Infections. (31st December 2020)

Authors:
Matsunaga, Yuko; Sonoyama, Takuhiro; Casanova, Luis; Nagata, Tsutae Den; Echols, Roger; De Gregorio, Fabio; Ogura, Eriko; Portsmouth, Simon
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S661
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of Hospitalization Incidence in Influenza Outpatients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study. (23rd December 2020)

Authors:
Komeda, Takuji; Takazono, Takahiro; Hosogaya, Naoki; Miyazaki, Taiga; Ogura, Eriko; Iwata, Shinpei; Miyauchi, Hideyuki; Honda, Keiichi; Fujiwara, Masakazu; Ajisawa, Yoshikazu; Watanabe, Hideaki; Kitanishi, Yoshitake; Hara, Kanae; Mukae, Hiroshi
Journal:
Clinical infectious diseases
Issue:
Volume 73:Number 5(2021)
Page Start:
e1181
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study. (26th October 2020)

Authors:
Komeda, Takuji; Takazono, Takahiro; Hosogaya, Naoki; Ogura, Eriko; Fujiwara, Masakazu; Miyauchi, Hideyuki; Ajisawa, Yoshikazu; Iwata, Shinpei; Watanabe, Hideaki; Honda, Keiichi; Kitanishi, Yoshitake; Hara, Kanae; Mukae, Hiroshi
Journal:
Clinical infectious diseases
Issue:
Volume 72:Number 11(2021)
Page Start:
e859
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐based health insurance claims database in Japan. Issue 6 (23rd December 2021)

Authors:
Hara, Azusa; Hara, Kanae; Komeda, Takuji; Ogura, Eriko; Miyazawa, Shogo; Kobayashi, Chiduru; Fujiwara, Masakazu; Yoshida, Manami; Urushihara, Hisashi
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 31:Issue 6(2022)
Page Start:
623
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. SP334IRON REGULATION BY MOLIDUSTAT, BAY 85-3934, A DAILY ORAL HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR IN PATIENTS WITH CHRONIC KIDNEY DISEASE. (18th May 2018)

Authors:
Akizawa, Tadao; Macdougall, Iain C; Berns, Jeffrey S; Bernhardt, Thomas; Taguchi, Megumi; Ogura, Eriko; Lekushi, Kazuma
Journal:
Nephrology dialysis transplantation
Issue:
Volume 33(2018)Supplement 1
Page Start:
i457
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗